CKD Bio Corp. (KRX:063160)
South Korea flag South Korea · Delayed Price · Currency is KRW
21,000
-200 (-0.94%)
Feb 20, 2026, 3:30 PM KST

CKD Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
7,2774,6553,4661,4634,49311,950
Short-Term Investments
5,0698,06969.0369.9971.584,856
Cash & Short-Term Investments
12,34712,7243,5351,5334,56416,806
Cash Growth
1814.78%259.97%130.54%-66.41%-72.84%-2.12%
Accounts Receivable
44,40225,89729,09523,98640,77329,619
Other Receivables
280.841,571811.091,3562,3871,436
Receivables
44,68327,46829,90625,34243,16031,055
Inventory
71,93478,50770,35659,11131,43828,402
Prepaid Expenses
3,065417484.92332.45283.04658.05
Other Current Assets
4,0584,34860.12,063596.671,342
Total Current Assets
136,087123,464104,34288,38280,04278,264
Property, Plant & Equipment
174,759181,509191,153191,189150,832104,101
Long-Term Investments
2,0042,0044.24.27.27.2
Other Intangible Assets
5,8743,8392,7732,9211,8691,905
Long-Term Accounts Receivable
-000-00226.72
Long-Term Deferred Tax Assets
815.7-----
Long-Term Deferred Charges
----34215.05
Other Long-Term Assets
632.251,775268.32966.12255.35-0
Total Assets
320,172312,591298,540283,463233,348184,520
Accounts Payable
9,6798,2329,9467,8227,0305,788
Accrued Expenses
7,6356,0375,1524,4794,1273,164
Short-Term Debt
35,68845,70012,92019,2477,4002,800
Current Portion of Long-Term Debt
22,70010,6006,401-56.456.4
Current Portion of Leases
730.27715.33710.22715.59680.48-
Current Income Taxes Payable
---325.693,073696.84
Other Current Liabilities
10,82510,3079,18113,52522,65611,130
Total Current Liabilities
87,25781,59144,31146,11445,02423,636
Long-Term Debt
98,86380,37389,26959,20019,0002,056
Long-Term Leases
1,1461,53779.2681.691,239-
Pension & Post-Retirement Benefits
-00846.9-01,4402,919
Long-Term Deferred Tax Liabilities
-118.781,4807,7417,2407,659
Other Long-Term Liabilities
1,3241,1721,064978.33941.72587.53
Total Liabilities
188,590164,792137,049114,71574,88536,858
Common Stock
13,71513,71513,71513,71513,07413,074
Additional Paid-In Capital
29,50129,50129,50129,50127,38927,389
Retained Earnings
87,738103,800118,866125,919120,039109,239
Treasury Stock
-----1,640-1,640
Comprehensive Income & Other
627.4782.99-590.46-386.93-398.68-400
Shareholders' Equity
131,582147,799161,491168,748158,463147,662
Total Liabilities & Equity
320,172312,591298,540283,463233,348184,520
Total Debt
159,127138,925109,37979,84428,3764,913
Net Cash (Debt)
-146,780-126,201-105,844-78,311-23,81211,893
Net Cash Per Share
-26756.44-23004.34-19293.66-14474.11-4421.142208.19
Filing Date Shares Outstanding
5.495.495.495.495.135.39
Total Common Shares Outstanding
5.495.495.495.495.395.39
Working Capital
48,83041,87460,03142,26835,01854,628
Book Value Per Share
23985.2126941.4029437.2030759.9729421.5627416.15
Tangible Book Value
125,708143,960158,718165,827156,594145,756
Tangible Book Value Per Share
22914.4226241.6128931.7430227.5229074.5327062.41
Land
58,75358,75358,75358,75358,75350,958
Buildings
111,358111,339112,056105,06342,33541,905
Machinery
182,866179,305172,468159,281125,958121,872
Construction In Progress
1,651399.751,08910,57554,49013,427
Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.